①What are the highlights of the strategic cooperation between Hai Zhi Technology and Zhipu? ②Green Tea Group's annual profit increased by more than 30% year-over-year. What is the scale?
Cailian Press, February 24th, by reporter Fengyi Feng. Cailian Press brings you important announcements for Hong Kong stocks today.
1) Corporate News
Maoyan Entertainment (01896.HK): Revenue for the fiscal year 2025 is RMB 4.6 billion to 4.7 billion, representing a year-over-year growth of approximately 12.7% to 15.1%; net profit is RMB 540 million to 590 million, representing a year-over-year increase of approximately 196.9% to 224.4%.
Green Tea Group (06831.HK): Expected net profit for 2025 is RMB 460 million to 508 million, representing a year-over-year increase of approximately 31.4% to 45.1%.
Abundant Life Services (00331.HK): Announced interim results for the six months ended December 31, 2025. Revenue was HKD 3.777 billion, representing a year-over-year decrease of 7.7%; net profit was HKD 216 million, representing a year-over-year decrease of 10.6%.
Chinese Estates Holdings (00127) announced that the group expects to achieve a 75% to 85% reduction in losses for 2025, while revenue is projected to decrease by 5% to 15%. In 2024, revenue amounted to HKD 3.37 billion, and the consolidated net loss attributable to owners of the company was HKD 2.108 billion.
SmarTone Telecommunications (00315.HK): Announced interim results with revenue of HKD 3.561 billion, representing a year-over-year increase of 2%; profit was HKD 278 million, representing a year-over-year increase of 8%.
Parkson Retail Group (03368.HK): Total operating income for 2025 was RMB 3.698 billion, representing a year-over-year decrease of 0.8%, and same-store sales decreased by 16.6% year-over-year; net loss was RMB 186 million, representing a year-over-year increase of 6.35%.
Hai Zhi Technology Group (02706.HK): Entered into a strategic cooperation framework agreement with Zhipu (02513.HK) to carry out strategic cooperation in areas such as model training and application scenario implementation.
The announcement stated that both parties will carry out strategic cooperation in areas such as model training and application scenario implementation. Hai Zhi Technology Group focuses on developing Atlas graph solutions and industry-level intelligent agents through graph-model integration technology and provides industry-level artificial intelligence solutions. Zhipu is a leading artificial intelligence company in China, dedicated to pursuing innovation in Artificial General Intelligence (AGI).
Transcenta Holding-B (06628.HK): Will attend Oppenheimer’s 36th Annual Healthcare & Life Sciences Conference.
Henlius (02696.HK): Amendment to the licensing agreement for Hansizhuang with ABBOTT and KGBIO.
Hengrui Pharma (01276.HK): Marketing authorization application for SHR-1918 injection accepted and included in the priority review process.
Dongyangguang Pharma (06887.HK): Clinical trial application for HEC-648 injection, a novel monoclonal antibody targeting the Nipah virus G protein, accepted by China's National Medical Products Administration.
Tiantu Investment (01973.HK): Completed the sale of a minority stake in Yoplait China.
Federal Pharmaceutical (03933.HK): Phase II clinical study of UBT251 injection completed in Chinese overweight/obese patients.
Duality Biologics-B (09606.HK): Research findings for core product DB-1311/BNT324 presented at the 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium.
2) Updates on shareholding changes and share repurchases
Anhui Conch Cement (00914.HK): Controlling shareholder Anhui Conch Group plans to increase its holdings of company A-shares by 700 million to 1.4 billion yuan.
Xiaomi Group-W (01810.HK): Repurchased 2.7942 million shares for HK$99.998 million at a price range of HK$35.64 to HK$35.92 per share.
Geely Auto (00175.HK): Repurchased 3.18 million shares for HK$53.2801 million at a price range of HK$16.67 to HK$17.10 per share.
NetEase Cloud Music (09899.HK): Repurchased 93,700 shares for HK$14.9998 million at an average price of HK$160.08 per share.
Meitu (01357.HK): Repurchased 2.1985 million shares at a cost of HKD 12.5009 million, with repurchase prices ranging from HKD 5.64 to HKD 5.73 per share.
